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Hyperhomocysteinemia is prevalent among patients with
chronic kidney disease (CKD) and has been linked to
progressive kidney and vascular diseases. Increased
glomerular mesangial cell (MC) turnover, including
proliferation and apoptosis, is a hallmark of CKD. Activation
of p38-mitogen-activated protein kinase (p38-MAPK) has
been linked to apoptosis in many cell lines. Accordingly, we
studied the effect of homocysteine (Hcy) on MC p38-MAPK
signalling and apoptosis. Hcy (50 lM/24 h) increased MC
apoptosis as determined by terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate (dUTP) nick
end labelling (TUNEL) and single-stranded DNA (ssDNA)
analysis. In addition to increases in pro-caspase-3 protein and
caspase-3 activity, cells exposed to Hcy manifested enhanced
reactive oxygen species content. Hcy increased p38-MAPK
activity (fivefold), with maximal effect at 50 lM and 20 min;
p38-MAPK activation was attenuated by N-acetylcysteine
(Nac) and catalase (Cat), further indicating that the effect was
via oxidative stress. Confocal microscopy revealed activation
and nuclear translocation of p38-MAPK that was attenuated
by Cat. In addition, Hcy-induced apoptosis as determined by
TUNEL and ssDNA assay was abrogated by Nac, Cat, and
SB203580 (p38-MAPK inhibitor). We conclude that in MC, Hcy
(i) activates p38-MAPK and increases p38MAPK nuclear
translocation via an oxidative stress dependent mechanism
and (ii) induces DNA damage and apoptosis that is
dependent on oxidative stress and p38-MAPK activation.
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The mechanism(s) that lead to reduction in glomerular cell
numbers and progressive glomerulosclerosis are unresolved.
Podocyte loss is an early event in proteinuric kidney disease
and glomerulosclerosis.1 On the other hand, mesangial cell
(MC) proliferation and hypertrophy and mesangial matrix
expansion are key events in progression of some forms of
kidney disease.2,3 Importantly, MC apoptosis or programmed
cell death plays a key role in both clinical and experimental
kidney diseases.4,5 Although apoptosis is a necessary
mechanism for tissue development and remodelling,6 in
certain circumstances it may contribute to organ dysfunction
and disease progression.4,7
Homocysteine (Hcy) or its metabolite S-adenosylhomo-
cysteine cause apoptosis of neuronal cells,8 myeloid leukemia
cell line HL60,9 and vascular endothelial cell.10 Hyperhomo-
cysteinemia characterizes all forms of chronic kidney diseases
(CKDs), but its role in the development and progression of
renal disease is not well defined.11,12 Recently, p38-mitogen-
activated protein kinase (p38-MAPK) has been implicated in
apoptosis of diverse cells, including cardiac myocytes13 and
vascular smooth muscle cells (VSMCs).14 The generation of
reactive oxygen species (ROS) activates p38-MAPK and p38-
MAPK-dependent signalling in various cells and tissue.15,16
MC apoptosis is also induced by ROS,17,18 but the role
of p38-MAPK in this ROS-dependent MC apoptosis is
not defined. Given the observations that (i) ROS activate
p38-MAPK,15,16 (ii) Hcy increases oxidant stress,19,20 and
(iii) both hyperhomocysteinemia and p38-MAPK activation
have been associated with apoptosis13,14 we hypothesize that
Hcy induces oxidative stress which leads to MC apoptosis via
a p38-MAPK-dependent mechanism.
RESULTS
Hcy induced apoptosis in MC
These experiments examined the impact of Hcy on MC
apoptosis. Incubation of MC with Hcy (50 mM; 24 h) led to
apoptosis as determined by terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate (dUTP) nick
end labelling (TUNEL) (Figure 1a and b) and DNA
fragmentation (Figure 1c). In addition, MC pretreated with
Hcy (15–100 mM; 371C/24 h) manifested a dose-dependent
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increase in ssDNA levels, with a 1.5 to twofold increase
occuring at 50 mM and increasing to threefold with 100 mM
Hcy when compared with control and L-cysteine-treated cells
(Figure 1d). These results suggest induction of MC injury
and death by high Hcy concentrations.
Induction of caspase-3 by Hcy in MCs
Caspase activation is a characteristic and stereotyped feature of
cell undergoing apoptosis.21,22 To further support our
observation of MC apoptosis in response to pathophysiologic
Hcy levels, caspase-3 activity assay, and procaspase-3 immuno-
blotting were performed on total cell lysates. MC exposed to
Hcy (50mM) manifested increases in procaspase-3 protein and
caspase-3 activity (Figure 2; Po0.05, n¼ 4) supporting our
observation of Hcy-induced MC apoptosis, and indicating the
activation an execution pathway involving caspase-3.
p38-MAPK activation and translocation in MC in response to
Hcy
Subsequently, the effect of Hcy on MC p38-MAPK signalling
was characterized. Incubation of MC with Hcy (5 mM to
1 mM; 1 h) led to an increase in p38-MAPK activity that was
maximal at 50 mM (Figure 3a). Accordingly, we chose to study
50 mM, as this plasma level is commonly seen in patients with
CKD.12 Time course studies with Hcy (50 mM) revealed
maximal p38-MAPK activity after 20 min, with decay there-
after (Figure 3b). Consequently, all subsequent experiments
were performed at this time point. Activation of p38-MAPK
was specific to Hcy, as L-cysteine (50 mM for 20 min) was
without effect (data not shown). Subsequently, we observed
that Hcy-induced caspase-3 enzymatic activity was abrogated
by the p38-MAPK inhibitor SB203580 (Figure 3c).
p38-MAPK nuclear translocation occurs subsequent to its
activation.23 Using confocal microscopy, we observed that
p38-MAPK activation was accompanied by translocation of
phospho-(activated) p38-MAPK into the nucleus (Figure 3e
and f) that was abolished by preincubation with catalase
(Cat) (Figure 3g and h).
Increased intracellular ROS in MC exposed to Hcy
Given the ability of Cat to prevent Hcy-induced p38-MAPK
translocation, ROS generation was assessed using a cell-
permeant fluoroprobe (carboxy 5-(and 6)-chloromethyl-
20,70-dichlorodihydrofluorescein diacetate (CM-H2DCFDA)),
after cells were exposed to Hcy with and without Nac
and Cat. In accord with our earlier findings,24 we observed
that MC exposed to Hcy exhibited increased fluorescence
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Figure 1 | MC undergo apoptosis following exposure to Hcy.
(a and b) MC were incubated with Hcy (50 mM/24 h), fixed (3.7%
formaldehyde), permeabilized (triton X-100), then labelled (DMEM/
0.5% FBS; 24 h) by TUNEL. Cells (b, green) were mounted using
antifade with 40 ,6-diamidino-2-phenylindole, dihydrochloride (blue
nuclei; a) as detailed in ‘Materials and Methods’; original
magnification  40. Nuclear condensation and fragmentation is
noted in (a) (arrows). (b) Depicts TUNEL staining of cells from 1A
identifying apoptotic nuclei (fluorescein isothiocyanate (FITC)-green
fluorescence; arrowhead); non-apoptotic cells do not reveal FITC
staining. (c) DNA fragmentation: Lane 1 – molecular weight marker;
Lane 2 – Control; Lane 3 – L-cysteine (100mm); Lanes 4 to 6 – Hcy 50,
100, and 250 mm, respectively. (d) ssDNA increases in MC (70–80%
confluent) exposed to Hcy (50–250 mM) whereas L-cysteine (100 mM)
is ineffective. *Po0.05, n¼ 5; #Po0.01, n¼ 5.
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Figure 2 | Hcy increases procaspase-3 protein and caspase-3
activity. (a) Procaspase-3 protein and (b) caspase-3 activity are
increased by Hcy (a). Cells were exposed to L-cysteine (100 mM) or Hcy
(15–100 mM; 24 h) as detailed in ‘Materials and Methods’. Caspase-3
was detected with rabbit polyclonal anti-caspase-3 primary. Protein
loading was assessed by b-actin immunoblots. *Po0.05, n¼ 4.
(b) Caspase-3 activity was determined using a Caspase-3 cellular
activity assay kit (product No. 235419; Calbiochem). Assays were
performed on cell lysate using 200 mM DEVD-pNA caspase-3 substrate
(3 h/371C); recombinant caspase-3 was used as a positive control.
DEVD-pNA substrate cleavage (pmol) was estimated by the product
optical density (OD405nm) of cleaved species (pNA)pmol pNA/
OD405nm (determined with supplied pNA). Caspase-3 activity (pmol/
min/mg) was determined from the quotient of the rate (pmol/min) of
DEVD-pNA cleavage and cell extract protein. *Po0.05, n¼ 5.
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(Figure 4c and f; Po0.001, n¼ 4) that was diminished by the
Nac and Cat (Figure 4d–f). These observations are consistent
with an interpretation of Hcy-induced intracellular ROS.
Role of oxidative stress and p38MAPK in MC exposed to Hcy
To further link ROS to p38-MAPK activation, hydrogen
peroxide (H2O2) was employed as an ROS.
25,26 MC exposed
to H2O2 (50 mM; 20 min) manifested a significant (6-fold)
elevation in p38-MAPK activity (Figure 5a), suggesting that
in MC, ROS activate p38-MAPK.
Oxidative stress may lead to DNA damage and apoptosis17
and, in some instances, p38-MAPK activation may mediate
apoptosis.13 To determine whether Hcy-induced MC apop-
tosis was mediated by oxidative stress and p38-MAPK, MCs
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Figure 3 | Hcy activates p38-MAPK in a concentration- and time-dependent manner, increases caspase-3 activity through p38-MAPK
and induces p38-MAPK nuclear translocation. (a and b) p38-MAPK was measured in MC lysates following immunoprecipitation and
subsequent detection of phosphorylation of an ATF-2 fusion protein. *Po0.05, n¼ 3. (c) Demonstrates p38-MAPK-dependent Hcy-induced
caspase-3 activity in MC lysates that was measured as detailed in the ‘Materials and Methods’. (d–h) *Po0.05, #Po0.01; n¼ 4. Assess nuclear
translocation of phospho-p38-MAPK in Hcy-challenged MC without or with inhibitors. (d) Negative control (secondary antibody only);
(e) Background cytoplasmic and nuclear staining in control MC; (f) Hcy (50 mM) increased nuclear translocation of p38 MAPK; (g) preincubation
with Cat (300 U/ml) attenuated the nuclear phospho-p38 MAPK. (h) Quantification of nuclear p38-MAPK was estimated using Image J (NIH,
USA); 40 nuclei were analyzed/condition. Relative intensity represents the ratio pixel density/nucleus from (d) control to that from MC exposed
to (e) Hcy or (f) Hcy and Cat. n¼ 3, *Po0.05.
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were incubated with Hcy (50 mM) in the presence of known
inhibitors of oxidative stress27,28 (Cat (300 U/ml) or Nac
(1 mM)) or a p38MAPK inhibitor (SB203580 (10 mM)). Our
analysis revealed that Hcy-mediated p38-MAPK activation
was abolished by the SB203580, as well as by Cat and Nac
(Figure 5b).
Finally, to determine whether oxidative stress and p38-
MAPK activation by Hcy, were important for apoptosis, MC
were preincubated (10 min) with Cat (300 U/ml) or
SB203580 before Hcy exposure. TUNEL and ssDNA analyses
demonstrated that Hcy mediated MC apoptosis was inhibited
by Cat and SB203580 (Figures 6a and b), further implicating
oxidative stress and p38-MAPK activation as mediators of
Hcy-induced MC apoptosis.
DISCUSSION
CKD is characterized by a progressive increase in serum Hcy
levels11,29 that may contribute to cardiovascular disease,30
and some pathologic effects of Hcy have been attributed to
oxidative stress.19,20 VSMCs proliferate in the presence of
Hcy31,32 with upregulation of cyclin A33 and the antioxidant
Nac inhibits VSMC proliferation in response to Hcy.34
However, apoptosis has also been observed when VSMC are
exposed to Hcy.35 In contrast, vascular endothelial cells
respond to Hcy challenge with growth inhibition and
apoptosis.36–38
Recently, we have demonstrated that in MC Hcy increased
DNA synthesis, proliferation and endoplasmic reticulum stress
in association with activation of p42/44 MAPK (extracellular
signal-regulated kinase).24 In addition, whereas ROS increased
in MC exposed to Hcy, ROS generation was unrelated to
extracellular signal-regulated kinase activation. The present
study further examined the influence of Hcy on MC turnover
in vitro; specifically, we assessed Hcy’s role in MC DNA
damage and apoptosis. These studies are particularly relevant
given (a) our prior observations of Hcy’s influence on MC
growth, (b) Hcy’s effect on growth, proliferation and death of
the closely related VSMC, and (c) data derived from
epidemiologic studies demonstrating that Hcy levels predict
CKD, independent of other known risk factors.39
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Figure 4 | Assessment of Hcy-induced oxidative stress. Generation of intracellular ROS was determined with the cell-permeant fluoroprobe
CM-H2DCFDA. (a) Control cells (no Hcy), (b) L-cysteine (100 mM), (c) Hcy with either (d) Cator (e) Nac. Analyses were performed as detailed
in ‘Materials and Methods’. Representative images from four such experiments performed in triplicates are depicted; original magnification
 40. (f) Relative intensity represents the ratio pixel density/cell (estimated using Image J (NIH, USA)) from (a) control to that from (b) MC
exposed to L-cysteine, (c) Hcy, (d) Hcy and Cat or (e) Hcy and Nac. Forty cells were analyzed from each condition. *Po0.001, n¼ 4; #Po0.01,
n¼ 4.
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Figure 5 | Hcy-induced p38-MAPK activation in MC is
ROS-dependent. (a) H2O2 activates p38 MAPK in glomerular MC.
Representative blot for three experiments performed in duplicates
are shown. Lower panel depicts densitometry. (b) p38-MAPK
activation by Hcy (50 mM) is inhibited by Nac, (1 mM), Cat. (300 U/ml)
and SB203580 (10mM). Activated p38-MAPK was measured in
immunoprecipitates from lysates by detection of phosphorylation
of an ATF-2 fusion protein by Western blotting; experiments were
performed three times in duplicates. *Po0.01, n¼ 3; #Po0.02, n¼ 3.
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Our initial observation was that in MC challenged with
Hcy (50 mM/24 h), there was increased DNA damage and
apoptosis (Figure 1). ssDNA assay confirmed that Hcy dose
dependently increased MC DNA damage in the concentra-
tion range from15 mM to100 mM (Figure 1). In unchallenged
MC and rat glomeruli, apoptotic cells represent about 2%40,41
and 0.1%,40 respectively; thus moderate changes could
contribute significantly to disease progression or resolu-
tion.42,43 Increases in apoptosis (from 0.05% at baseline to
0.5% at 120 days) has been observed in experimental CKD
using subtotal nephrectomized rats.44 Though numerically
small, these changes in glomerular apoptotic cells represent
significant increases in total apoptotic population. Accord-
ingly, our observed changes in apoptotic MC are of a
magnitude consistent with these other observations.
In concert with increased MC apoptosis following
exposure to Hcy, the activity of caspase-3 was increased in
Hcy-challenged MC. Caspases are cysteine proteases that are
activated by apoptotic stimuli and caspase-3 is a key enzyme
involved in execution of caspase-dependent apoptosis.
Others have observed caspase activation in MC undergoing
apoptosis.45,46 Our current observations are consistent with
these reports.
The second major observations that we made were that
(i) Hcy activates p38-MAPK in a time- and dose-dependent
manner that is linked to caspase-3 enzymatic activity
(Figure 3) and (ii) Hcy-induced p38-MAPK activation was
curtailed by inhibitors of oxidative stress (Figure 5). H2O2
may serve as an important surrogate and positive control for
demonstrating ROS involvement in physiologic and patho-
physiologic processes.25,26 In addition, p38-MAPK activation
may be mediated by ROS generation47,48 and/or p38-MAPK
activation may mediate some adverse consequences of
ROS generation.49 In our investigation of the effect of
H2O2 on p38-MAPK in glomerular MC, we observed that
H2O2 manifested marked activation of p38-MAPK (Figure 5).
On the basis of these results we infer that ROS generation
may play a role in Hcy-induced p38-MAPK activity in
glomerular MC.
Following MAPK activation, the active species are
translocated to the nucleus where they exert influences on
various processes.23,50 We next determined whether p38-
MAPK is translocated to MC nucleus in response to Hcy and
whether ROS were important in this regard. Indeed, in MC
exposed to Hcy (50 mM) there is enhanced nuclear phospho-
p38-MAPK above that observed in the basal state (Figure 3).
Furthermore, this latter event is attenuated by Cat suggesting
a role for H2O2 in enhanced nuclear localization of p38-
MAPK following exposure to Hcy.
The final observation in the current study is the finding
that the effect of Hcy on MC apoptosis could be attenuated
by Nac, Cat, and p38-MAPK inhibition (Figure 6). This
implicates an ROS-p38-MAPK pathway as a possible
mediator in Hcy-induced MC injury and death and is
consistent with previous observations in MC-related
VSMC.35,51 In the case of glomerular MC, although there
are no reports linking Hcy to cellular injury and death, we
and other have previously observed enhanced ROS genera-
tion when MC were exposed to Hcy.24,52 ROS generation
following Hcy exposure may be secondary to either enhanced
NADH oxidase activity,53,52 auto-oxidation54 or increased
intracellular H2O2.
9 In support of a role for Hcy in
intracellular ROS generation and in keeping with our
previous findings,24 we observed that MC exposed to Hcy
manifested increased ROS levels that were attenuated by
antioxidants Cat and Nac (Figure 4). Therefore, we infer that
Hcy causes MC injury and apoptosis through oxidant stress-
dependent mechanism(s), and our data indicate that p38-
MAPK activation downstream of ROS is the major producer
of the apoptotic effect.
Hcy causes renal injury in rats.42,55 Albumin excretion rate
was found be directly related to serum Hcy,55 whereas
creatinine clearance was inversely related to serum Hcy
levels.42 Hcy is also known to induce apoptosis and
proliferation in VSMC,35 which are phenotypically similar
to MC and respond similarly to injurious stress, proliferation
and matrix production. Hcy (10–20 mM) dose dependently
increased VSMC proliferation and induced VSMC apopto-
sis.35 Similarly, MC apoptosis have been correlated with
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mitotic activity.40 Accordingly, our earlier observations that
Hcy caused cell proliferation via extracellular signal-regulated
kinase signaling24 and the current findings that Hcy caused
apoptosis via p38-MAPK suggest a dual effect of Hcy on
cellular behaviour as have been demonstrated for other
agents, like angiotensin II.56
In summary, the findings of these series of experiments
identify Hcy as a cause of MC apoptosis, an event that is
linked to ROS generation and is mediated by p38-MAPK
activation (Figure 6). Our recent report documenting
calcium-dependent, extracellular signal-regulated kinase-
mediated MC proliferation in response to Hcy,24 together
the current findings suggest a role for Hcy in MC turnover
and may have implications for progression of glomerular
disease. Above all, these observations demonstrate a central
role for MAPK in cellular responses to Hcy. High plasma Hcy
levels are commonly seen are seen in CKD and hyperhomo-
cysteinemia levels have been associated with CKD risk.11,12
Given that apoptosis of glomerular MC have been observed
in various forms of CKD, these findings may have important
implication for development and progression of CKD. Future
studies aimed at testing this hypothesis in in vivo models are
necessary.
MATERIALS AND METHODS
Cell culture
Sprague–Dawley rat MC were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 20% fetal bovine
serum (FBS) (Invitrogen, CA, USA), streptomycin (100 g/ml),
penicillin (100 U/ml), and 2 mM glutamine at 371C in 95% air/5%
CO2 as described previously.
57 Cells from passage 5–10 were used
throughout these studies. All chemicals were obtained from Sigma-
Aldrich (St Louis, MO, USA) unless otherwise indicated.
Apoptosis detection
TUNEL assay. MC apoptosis was quantified with a commer-
cially available in situ cell death detection (Roche Canada, Laval,
Quebec, Canada). MCs were seeded onto glass cover slips in 12-well
plastic plates (1.5 105 cells/well) and maintained in DMEM/20%
FBS for 24 h. Culture media was changed to DMEM/0.5% FBS and
Hcy (50mM) with and without Cat (300 U/ml), Nac (1 mM), or
SB203580 (10 mM) for 24 h. Cells were fixed (3.7% formaldehyde in
phosphate-buffered saline (PBS); 20 min; room temperature),
washed ( 3, PBS), then permeabilized (Triton X-100 (0.1%;
2 min, 41C). Fixed cells were labelled by TUNEL (371C 1.0 h),
washed (PBS) and mounted onto glass slides using antifade mount
media with 40,6-diamidino-2-phenylindole, dihydrochloride (Vector
Laboratories Inc. CA, USA). Subsequently, confocal (Bio-Rad MRC-
600 confocal microscope, Bio-Rad, Mississauga, ON, USA) and
fluorescence microscopic (Nikon Instruments Inc., Lewisville, TX,
USA) analyses were performed.
ssDNA assay. This method is based on selective denaturation
of apoptotic cells by formamide and detection of denatured DNA by
monoclonal antibody.58 MC were seeded on to 96-well plates
(11 103 cells/well) and maintained in DMEM/10%FBS until cells
were 70–80% confluent. Culture media was changed to DMEM/
0.5% FBS for 24 h. Cells were then pretreated with L-cysteine
(100 mM) or Hcy (15 mM, 50 mM,100mM and 250 mM) with or without
Nac (1 mM), Cat (300 U/ml), or SB203580(10 mM) at 371C for 24 h
and analyzed for ssDNA apoptosis by enzyme-linked immunosor-
bent assay as per the manufacturer’s protocol (Chemicon Interna-
tional Inc, Temecula, CA, USA).
DNA fragmentation analysis. Cells (106) were washed with
PBS ( 1) and dislodged from culture dishes with a rubber
policeman. DNA fragmentation analysis was performed with a
commercially available kit according to the manufacturer’s specifi-
cation (R&D Systems, MN, USA).
Caspase-3 protein detection by Western blotting
Cultures were serum-starved overnight (DMEM/0.5% FBS for 24 h)
before the addition of L-cysteine (100 mM) or Hcy (15 mM, 50 mM and
100 mM). Subsequently, washed cells (PBS, 41C) were harvested
under non-denaturing conditions (41C/5 min) with lysis buffer
(20 mM Tris, pH 7.4; 150 mM NaCl; 1 mM ethylenediaminetetraacetic
acid; 1 mM ethylene glycol-bis(aˆ-aminoethyl ether)-N,N,N’,N’,-
tetraacetic acid; 1% Triton X-100; 1 mM glycerolphosphate, 1 mM
sodium orthovanadate; 1 mg/ml leupeptin; 1 mM phenyl methylsul-
phonyl fluoride). Protein was separated (10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis gel), electroblotted to a
nitrocellulose membrane (Schleicher and Schuell, Keene, NH, USA).
Procaspase-3 was detected with rabbit polyclonal anti-caspase-3
primary antibody (Biovision, Mountain View, CA, USA; antibody
diluted 1:2000 in 1 tris-buffered saline, 0.1% Tween-20 tris-
buffered saline) and an horseradish peroxidase-conjugated anti-
rabbit secondary antibody (Cell Signalling Technology, Danvers,
MA, USA; antibody diluted 1:4000 with Tween-20 tris-buffered
saline). Appropriate bands were identified with ECL Chemilumines-
cence Reagent (Amersham Biosciences, Little Chalfont, Buckin-
ghamshire, England) and followed by exposure to X-ray film
(X-OMAT, Kodak, Rochester NY, USA). Subsequently, immune
complexes were removed from the membrane (stripping buffer
(100 mM 2-mercaptoethanol, 2%sodium dodecyl sulfate, 62.5 mM
Tris-HCl (pH 6.7); 501C; 30 min) and protein loading was assessed
by re-blotting with anti-actin antibody (1:2000, Sigma, St Louis,
MO, USA) and an horseradish peroxidase-conjugated anti-rabbit
secondary antibody (1:4000) (Cell Signalling Technology).
Caspase-3 activity assay
Caspase-3 activity was determined using a Caspase-3 cellular activity
assay kit (product 235419; Calbiochem, San Diego, CA, USA). MCs
were pre-incubated with L-cysteine (100mM), Hcy (15mM, 50mM and
100mM), and Hcy (50mM) plus SB203580 (10mM). Cells were washed
(PBS; 41C), lysed and cell debris was cleared (centrifugation 10 000 g/
10 min at 41C). Cell lysates were transferred to 96-well microplate
containing 200mM DEVD-pNA caspase-3 substrate and incubated
(3 h/371C); recombinant caspase-3 was used as a positive control.
DEVD-pNA substrate cleavage (pmol) was estimated by the product:
-optical density (OD405nm) of cleaved species (pNA) pmol pNA/
OD405nm (determined with supplied pNA). Caspase-3 activity (pmol/
min/mg) was determined from the quotient of the rate (pmol/min) of
DEVD-pNA cleavage and protein content of cell extract.
p38-MAPK protein and activity
Protein isolation and Western blotting. These procedures
were performed using standard methodologies as we have previously
described.23 Initially, the time course and concentration dependence
of p38-MAPK activation in response to Hcy was studied and
subsequent experiments performed at 50 mM Hcy at 20 min. Serum-
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starved MCs (DMEM/0.5% FBS; 18 h) were exposed to Hcy and/or
inhibitors, and cell lysate was assayed for p38-MAPK protein and
activity as we have previously described.23 For Western blot analysis,
40 mg cell protein was separated on a 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gel and electroblotted to a
nitrocellulose membrane. p38-MAPK protein was identified with
p38-MAPK polyclonal primary antibody (1:1000) (New England
Biolabs, Beverly, MA, USA), horseradish peroxidase-conjugated
anti-rabbit secondary antibody (1:2000 New England Biolabs) and
LumiGlo chemiluminescent reagent (KPL Inc., Gaithersburg, MD,
USA).
Activity assays. After protein isolation from total cell lysate as
above, total protein (200 mg) was used for determination of p38-
MAPK activity as we have described.23 In brief, cell lysate phospho-
p38-MAPK was captured with phospho-p38-MAPK monoclonal
antibody (Thr180/Tyr 182) immobilized on protein A beads (1:100)
(New England Biolabs). P38-MAPK activity was determined with
ATP (200 mM) and activating transcription factor 2 (ATF-2) fusion
protein (2 mg) as substrates. Following electrophoresis (10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis) and electroblot-
ting to nitrocellulose membranes, phosphorylated ATF-2 was
identified with a phospho-specific ATF-2 (Thr 71) primary antibody
(1:1000) and an horseradish peroxidase-conjugated anti-rabbit
secondary antibody (1:2000).23
Immunofluorescent microscopy for p38-MAPK nuclear
translocation
This procedure was performed as described previously.23 After
incubation with Hcy with or without inhibitors, washing (thrice
with 1PBS), fixation (3.7% formaldehyde, 10 min, ambient
temperature) and permeabilization (0.1% Triton X-100, 41C for
2 min), cells were incubated (30 min; room temperature) with anti-
phospho-p38-MAPK (1:25 dilution; Thr180/Tyr182; New England
Biolabs). Subsequently, cells were incubated (30 min; room tem-
perature, light protected) with an Alexa 488 goat anti-rabbit IgG
(Hþ L) conjugate (1:50 in PBS; Molecular Probes, Eugene, OR,
USA). Laser scanning confocal microscopy (Bio-Rad MRC-600
confocal microscope; Bio-Rad) was performed anti-fade mounted
specimen. Pixel density per nucleus was estimated using Image J
(NIH, USA); 40 nuclei were analyzed per condition.
Detection of ROS
The generation of intracellular ROS was determined with the cell-
permeant fluoroprobe carboxy 5–(and 6)-chloromethyl-20,70-di-
chlorodihydrofluorescein diacetate (CM-H2DCFDA; Molecular
Probes) in cells exposed to Hcy, with and without NAC or Cat.
Analyses were performed as have been previously detailed.24 Washed
cells were loaded with CM-H2DCFDA (10 mMol/l; 20 min at 371C),
excess CM-H2DCFDA was removed, cells were washed (PBS) and
allowed to recover (45 min/371C/5% CO2). Digital images of
fluorescent cells (excitation 488 nm, emission 520 nm) were
captured a using Nikon Fluorescence Microscope (Nikon Instru-
ments Inc, Lewisville, TX, USA) and Olympus C-4000 Digital
Camera (Olympus America Inc, Melville, NY, USA). As above, pixel
density per cell was estimated using Image J (NIH, USA); 40 cells
were analyzed per condition.
Statistical analyses
Instat statistical package (Graphpad Inc) was used for statistical
analyses. Unpaired Student’s t-test was used to evaluate differences
between the means of two groups, whereas the Tukey and
Bonferroni tests were used for comparison of differences between
multiple means. Differences were considered significant at Po0.05.
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